Rewriting the MASLD ‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism
International Journal of Cancer · 15.11.2025 · 157 (10) · 1991-2003
DOI: 10.1002/ijc.70047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 22.07.2025. Verfasst von Chiara Aiello und 7 weiteren Autor:innen. Beteiligte Einrichtung: Microscopic and Ultrastructural Anatomy Research Unit, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Epigenesis, Genetic, Fatty Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Abnormal epigenetic patterns are crucial for the progression of metabolic‐associated steatotic liver disease (MASLD) and hepatocellular carcinoma (HCC) development. Recent research focused on the interplay between epigenetics and altered metabolic pathways in HCC from MASLD, suggesting that the reversibility of epigenetic changes offers potential for new therapeutic strategies. However, identifying effective epigenetic targets remains challenging due to the diverse etiologies of HCC. Targeting metabolic reprogramming, MASLD‐associated HCC shows promise in reducing lipid anabolism. In this context, a more comprehensive understanding of metabolomic changes closely tied to druggable epigenetic modifications is of utmost importance. This review provides a concise summary of the key factors driving hepatocarcinogenesis in MASLD and delves deeper into the epigenetic mechanisms. Finally, we aim to present an overview of the primary mechanisms concerning the intricate bidirectional interplay between the metabolome and epigenetic modifications in MASLD‐associated HCC, along with therapeutic strategies specifically targeting epigenetics and metabolomic alterations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microscopic and Ultrastructural Anatomy Research Unit, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
- Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department for BioMedical Research, Visceral Surgery and Medicine, University of Bern, Bern, Switzerland.
- Department of Pathology, Ospedale San Camillo Forlanini, Rome, Italy.
- Departmental Faculty of Sciences and Technology for Sustainable Development and One Health, Università Campus Biomedico di Roma, Rome, Italy.
- Liver Vascular Biology, IDIBAPS Biomedical Research Institute, CIBEREHD, Barcelona, Spain.
ORCID-Profile: Lorenzo Nevi
Zitieren
APA
Aiello, C., Felli, E., Musarra, T., Nevi, L., Altomare, A., Gracia-Sancho, J., Baiocchini, A., & Carotti, S. (2025). Rewriting the MASLD ‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism. International Journal of Cancer, 157(10), 1991-2003. https://doi.org/10.1002/ijc.70047
Vancouver
Aiello C, Felli E, Musarra T, Nevi L, Altomare A, Gracia-Sancho J, et al. Rewriting the MASLD ‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism. International Journal of Cancer. 2025;157(10):1991-2003. doi:10.1002/ijc.70047
BibTeX
@article{Aiello2025,
author = {Aiello, Chiara and Felli, Eric and Musarra, Teresa and Nevi, Lorenzo and Altomare, Annamaria and Gracia-Sancho, Jordi and Baiocchini, Andrea and Carotti, Simone},
title = {Rewriting the MASLD ‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism},
journal = {International Journal of Cancer},
year = {2025},
volume = {157},
number = {10},
pages = {1991--2003},
doi = {10.1002/ijc.70047}
}
EUVIMED